|
![]() |
REPORT
3rd
meeting of the ACTE
ADVISORY BOARD FOR AN INDEPENDENT STUDY INTO -
via conference call - Agenda Item 1: Opening of Meeting1. The Chairperson of the Advisory Board, Nancy Holtzman (ACTE), opened the meeting via conference call at 0900 hours EST on Friday, 6 July 2001. The attendance list is shown in Attachment A. She welcomed two new corporates to the Advisory Board: Dan Baillie (Block Drug Company) and Clive Armitage (Astra Zeneca Pharmaceuticals). This brings the total of corporates on the board to five. Agenda
Item 2: Approval of the Report of Last Meeting (12 June 2001) 2. The report was approved. However, it was re-iterated that more corporate participation was essential to the success of this study. Furthermore, the development of a data flow chart was becoming urgent. The Secretary agreed to circulate the draft version of this chart (see Attachment B). 3. It was noted
that the reports of the ACTE Advisory Board meetings would be publicly
available on the ACTE and IATA websites. (The web page address to the
IATA site from where relevant documents can be downloaded is shown immediately
below). Agenda Item 3: Update on Contacts with the Four Consultants4. The two small/medium companies had accepted to go forward and prepare an offer. However, the two large ones had declined. It was agreed that Bernard Harrop would approach a large company and Dennis Bailey/Mike Muller would contact another large company with a view to offer them a chance to pitch for this business. Agenda Item 4: Draft Procedures on How to Handle Consultant Selection Process5. It was agreed to invite all consultants to the next Advisory Board meeting in New York on 25 July. The morning session would allow each consultant individual time to outline their proposal for the study into CCIS. The afternoon session would open to all parties. It would start with a data flow presentation followed by a general Q&A session. The end of the meeting would be reserved for board members only to decide a way forward. 6. The group agreed to develop a "check list" to allow more scientific assessment of each consultant. A draft list is shown in Attachment C. Agenda Item 5: Progress Report Information Flow7. It was agreed to defer this item to the next meeting. Date and Place of Next Meeting/Conference Call 8. It was agreed that the next meeting would take place in New York on 25 July. Attendance
Record
Data Flow PDF (a)
Established presence: Scale
1 to 5 Europe (b)
Data Flow Expertise/Technology Understanding: Demonstrated understanding of data flow
(c)
Understanding of Airline: Business model (d)
Non biased: Ability to address issues in study without bias
(e)
available resources/capacity to perform: Staff to dedicate to study Priority of project (f)
Credibility: References Ability to deliver projects on time (g)
Thought Leadership: |
Home | About | Membership | ACTE Sponsors | Resources | Events | Members Only | Contact Us | Canada | EMEA | Asia/Pacific | Site Map |